We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Dexcom Hit With Atty Fees For 'Bad Faith' Patent Suit

Law360 (May 23, 2018, 10:16 PM EDT) -- Diabetes glucose monitoring company Dexcom Inc. has to pay attorneys’ fees to its New Hampshire-based rival after a California federal judge held that it acted in “bad faith” by continuing to litigate a patent case despite multiple court warnings, according to an order unsealed Tuesday.

San Diego-based Dexcom no longer had a viable patent suit against AgaMatrix Inc. after the court issued a claim construction order in August 2017, but the company pressed on anyway despite “repeated admonishments” that attorneys’ fees could be granted if the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.